Medical treatment based on an individual’s genetics is the future of medicine, according to government, academic and industry panelists participating at a July 23 roundtable held by the House Energy and Commerce Committee.

Developed at the molecular level, personalized medicine is a growing practice area that holds tremendous promise for providing patients with cures to diseases that are tailored specifically to their genetic makeup, say advocates. Not only does this “precision” medicine have the potential to improve patient care and result in better outcomes by increasing the ability to predict which medical treatments will be safe and effective, but at the same time it can lead to a more efficient U.S. healthcare system and control costs by identifying the right drug for a patient.   

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access